https://www.selleckchem.com/pr....oducts/rxdx-106-cep-
To evaluate efficacy and safety of Gla-300 with Gla-100 in a patient-level meta-analysis among large East Asian patients with type 2 diabetes mellitus (T2DM). A patient level meta-analysis of three EDITION studies with similar design and endpoints were conducted over 6-months treatment period. The analysis included 547 patients treated with Gla-300 and 348 patients treated with Gla-100. Over 6-month treatment period, mean change in HbA1c was similar for Gla-300 [Least square (LS) mean, (SE) -1.13 (0.05) % and Gla-100 -1.14 (0
Like
Comment
Share
